KR960010004A - Headache prevention and treatment composition - Google Patents

Headache prevention and treatment composition Download PDF

Info

Publication number
KR960010004A
KR960010004A KR1019940022958A KR19940022958A KR960010004A KR 960010004 A KR960010004 A KR 960010004A KR 1019940022958 A KR1019940022958 A KR 1019940022958A KR 19940022958 A KR19940022958 A KR 19940022958A KR 960010004 A KR960010004 A KR 960010004A
Authority
KR
South Korea
Prior art keywords
vitamin
composition
methionine
headaches
present
Prior art date
Application number
KR1019940022958A
Other languages
Korean (ko)
Other versions
KR0128705B1 (en
Inventor
강상모
Original Assignee
강상모
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 강상모 filed Critical 강상모
Priority to KR1019940022958A priority Critical patent/KR0128705B1/en
Publication of KR960010004A publication Critical patent/KR960010004A/en
Application granted granted Critical
Publication of KR0128705B1 publication Critical patent/KR0128705B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

본 발명은 비타민 E를 함유함을 특징으로 하는 긴장성 두통 및 편두통 예방 및 치료제 조성물에 관한 것이다. 본 발명의 조성물에는 또한 비타민 E 이외에도 바람직하게는 추가로 비타민 C, 비타민 B로 구성된 그룹에서 선택된 하나 또는 그 이상의 성분 및 메치오닌을 함유한다. 본 발명에 따르는 조성물은 실질적으로 인체에 무해한 것으로 알려져 있는 비타민류 및 아미노산 성분들로 구성되기 때문에 기존의 의약품에서 야기되었던 각종 부작용이 없이 효과적으로 두통, 특히 긴장성 두통 및 편두통을 예방 또는 치료할 수 있다.The present invention relates to a composition for preventing and treating tonic headache and migraine, characterized by containing vitamin E. The composition of the present invention also contains, in addition to vitamin E, one or more components selected from the group consisting of vitamin C, vitamin B and methionine. Since the composition according to the present invention is composed of vitamins and amino acid components that are known to be substantially harmless to the human body, it is possible to effectively prevent or treat headaches, especially tension headaches and migraine headaches, without various side effects caused by conventional medicines.

Description

두통 예방 및 치료제 조성물Headache prevention and treatment composition

본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음Since this is an open matter, no full text was included.

Claims (9)

비타민 E를 함유함을 특징으로 하는 긴장선 두통 및 편두통의 예방 및 치료제 조성물.A composition for preventing and treating tension line headaches and migraines, comprising vitamin E. 제1항에 있어서, 추가로 비타민 C, 비타민 B로 구성된 그룹에서 선택된 하나 또는 그 이상의 성분을 함유함을 특징으로 하는 조성물.The composition of claim 1, further comprising one or more components selected from the group consisting of vitamin C and vitamin B. 제1항에 있어서, 추가로 메치오닌을 함유함을 특징으로 하는 조성물.The composition of claim 1, further comprising methionine. 제1항에 있어서, 비타민 E가 성인 체중 kg 당 1일 0.5 I.U.E 내지 20 I.U.가 투여되도록 제형화됨을 특징으로 하는 조성물.The composition of claim 1, wherein the vitamin E is formulated to administer 0.5 I.U.E to 20 I.U. per kg body weight per adult. 제1항에 있어서, 비타민 E, 비타민 C, 비타민 B 및 메치오닌을 함유함을 특징으로 하는 조성물.The composition of claim 1 containing vitamin E, vitamin C, vitamin B and methionine. 제5항에 있어서, 비타민 E, 비타민 C, 비타민 B 및 메치오닌을 중량 기준으로 1-40:1-40:1-10:1-40의 비로 함유함을 특징으로 하는 조성물.6. The composition of claim 5, which contains vitamin E, vitamin C, vitamin B and methionine in a ratio of 1-40: 1-40: 1-10: 1-40 by weight. 제6항에 있어서, 비타민 E, 비타민 C, 비타민 B 및 메치오닌을 중량 기준으로 2-10:2-10:1-5:2-20의 비로 함유함을 특징으로 하는 조성물.The composition of claim 6, which contains vitamin E, vitamin C, vitamin B and methionine in a ratio of 2-10: 2-10: 1-5: 2-20 by weight. 제1 내지 7항중의 어느 하나에 있어서, 추가로 적어도 하나의 약제학적으로 허용되는 담체를 함유함을 특징으로 하는 조성물.8. A composition according to any one of claims 1 to 7, further containing at least one pharmaceutically acceptable carrier. 제8항에 있어서, 정제, 연질캅셀제 또는 액제로 제형화됨을 특징으로 하는 조성물.9. A composition according to claim 8, formulated in tablets, soft capsules or solutions. ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.※ Note: The disclosure is based on the initial application.
KR1019940022958A 1994-09-13 1994-09-13 Pharmacentical composition for headache KR0128705B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1019940022958A KR0128705B1 (en) 1994-09-13 1994-09-13 Pharmacentical composition for headache

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1019940022958A KR0128705B1 (en) 1994-09-13 1994-09-13 Pharmacentical composition for headache

Publications (2)

Publication Number Publication Date
KR960010004A true KR960010004A (en) 1996-04-20
KR0128705B1 KR0128705B1 (en) 1998-04-04

Family

ID=19392567

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019940022958A KR0128705B1 (en) 1994-09-13 1994-09-13 Pharmacentical composition for headache

Country Status (1)

Country Link
KR (1) KR0128705B1 (en)

Also Published As

Publication number Publication date
KR0128705B1 (en) 1998-04-04

Similar Documents

Publication Publication Date Title
KR950002785A (en) Parathyroid hormone and raloxyphene to increase bone mass
HK1003978A1 (en) Composition for the treatment of schizophrenia
KR910019640A (en) Pharmaceutical composition for the prevention and treatment of Clostridium difficile hydrosis and gastric colitis
KR930702000A (en) Use of parosetin for the treatment of old age dementia, edema, migraine headaches, or poor food
MY111260A (en) Pharmaceutical composition for the treatment of nicotine dependence
CA2173147A1 (en) Anti-obesity agent
KR890012644A (en) Liver Disorder Remedy
KR970064617A (en) Periodontal disease prevention and treatment composition
BR0210744A (en) Synergistically Pharmaceutical Combination for the Prevention or Treatment of Diabetes
MX9403088A (en) Indole derivatives.
IL121272A (en) Pharmaceutical compositions comprising adenosine and their use for treating or preventing leukopenia
MC1930A1 (en) ANTIVIRAL PRODUCT
KR960010004A (en) Headache prevention and treatment composition
GB2306885B (en) Supersaturated Pharmaceutical Compositions
GR3034142T3 (en) Composition for the treatment or prevention of herpes
PT862433E (en) TOPICAL PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF DERMATOSES INDUCED BY PITYROSPORUM OVAL
KR950026522A (en) Headache prevention and treatment composition containing beta-carotene
DE69327074D1 (en) Substituted 1,2,4-triazine-3,5-dione derivatives and medicaments containing them, in particular for the treatment of coccidiosis
KR900017587A (en) Use of thiazole derivative tiprotimod for the manufacture of a therapeutic agent for viral infection
KR930019216A (en) Tumor treatment
KR930017579A (en) Neuroprotective agents
KR900017599A (en) Pharmaceutical composition for tumor treatment
KR950007852A (en) Arthritis treatment containing uracil as an active ingredient
KR970073595A (en) Composition for the prevention and treatment of alcoholic disorders
KR950700063A (en) Brofaromine as an agent for treating post-traumatic stress

Legal Events

Date Code Title Description
A201 Request for examination
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
LAPS Lapse due to unpaid annual fee